EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum P1NP and magnesium levels in male patients with major depressive disorder: association with depression severity

Rana Ali Jasim, Mohammed Imran Hamzah, Uday Khalid Abdul Jabbar

Romanian Journal of Psychiatry & Psychotherapy · 30.06.2026 · 28 (2) · 68

DOI: 10.37897/rjpp.2026.2.2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Romanian Journal of Psychiatry & Psychotherapy, online erschienen am 30.06.2026. Verfasst von Rana Ali Jasim und 2 weiteren Autor:innen. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Depression affects hundreds of millions of people worldwide and is a leading cause of disability. Reliable biomarkers could improve understanding of its pathophysiology and help assess disease severity. Procollagen type 1 N-terminal propeptide (P1NP), a marker of bone formation released during type I collagen synthesis, and magnesium, an essential element in neurotransmission, have been implicated in depressive disorders.

Objective

To evaluate serum P1NP and magnesium levels in men with major depressive disorder and investigate their associations with depression severity.

Methods

This case-control study included 130 adult men: 90 patients with major depressive disorder (MDD), equally divided into mild, moderate, and severe groups, and 40 healthy controls. Serum P1NP was measured using ELISA, and serum magnesium was measured spectrophotometrically.

Results

Mean age did not differ significantly between patients and controls (p = 0.991). Serum P1NP levels increased progressively with depression severity, whereas magnesium levels decreased significantly across severity groups (p < 0.001). P1NP and magnesium levels showed a moderate inverse correlation (r = −0.359, p < 0.001). Magnesium showed better discriminatory performance than P1NP (AUC = 0.863, sensitivity = 72.22%, specificity = 92.50%), whereas P1NP showed modest discriminatory performance (AUC = 0.709, sensitivity = 51.11%, specificity = 87.50%).

Conclusion

Serum P1NP levels increased and magnesium levels decreased with worsening depression severity. Both biomarkers were associated with depression severity in men with MDD; however, larger prospective studies are required before clinical application.

Zitieren

APA

Jasim, R. A., Hamzah, M. I., & Jabbar, U. K. A. (2026). Serum P1NP and magnesium levels in male patients with major depressive disorder: association with depression severity. Romanian Journal of Psychiatry & Psychotherapy, 28(2), 68. https://doi.org/10.37897/rjpp.2026.2.2

Vancouver

Jasim RA, Hamzah MI, Jabbar UKA. Serum P1NP and magnesium levels in male patients with major depressive disorder: association with depression severity. Romanian Journal of Psychiatry & Psychotherapy. 2026;28(2):68. doi:10.37897/rjpp.2026.2.2

BibTeX
@article{Jasim2026,
  author = {Jasim, Rana Ali and Hamzah, Mohammed Imran and Jabbar, Uday Khalid Abdul},
  title = {Serum P1NP and magnesium levels in male patients with major depressive disorder: association with depression severity},
  journal = {Romanian Journal of Psychiatry & Psychotherapy},
  year = {2026},
  volume = {28},
  number = {2},
  pages = {68},
  doi = {10.37897/rjpp.2026.2.2}
}
Kostenlos starten →